Trial Profile
Prospective Evaluation of Rifalazil Effect On Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia Seropositive Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Rifalazil (Primary)
- Indications Chlamydial infections; Peripheral arterial disorders
- Focus Therapeutic Use
- Acronyms PROVIDENCE-1
- Sponsors ActivBiotics
- 07 Nov 2007 Status change from in progress to completed.
- 02 Oct 2006 Status change
- 08 Nov 2005 New trial record.